<html>

<head>
<meta http-equiv=Content-Type content="text/html; charset=windows-1252">
<meta name=Generator content="Microsoft Word 15 (filtered)">
<title>SJR142</title>
<style>
<!--
 /* Font Definitions */
 @font-face
	{font-family:"Cambria Math";
	panose-1:2 4 5 3 5 4 6 3 2 4;}
@font-face
	{font-family:"Albertus Extra Bold";
	panose-1:2 14 8 2 4 3 4 2 2 4;}
@font-face
	{font-family:Marlett;
	panose-1:0 0 0 0 0 0 0 0 0 0;}
@font-face
	{font-family:Tahoma;
	panose-1:2 11 6 4 3 5 4 4 2 4;}
@font-face
	{font-family:"Segoe UI";
	panose-1:2 11 5 2 4 2 4 2 2 3;}
 /* Style Definitions */
 p.MsoNormal, li.MsoNormal, div.MsoNormal
	{margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:120%;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	letter-spacing:.2pt;}
p.MsoCommentText, li.MsoCommentText, div.MsoCommentText
	{mso-style-link:"Comment Text Char";
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	font-size:10.0pt;
	font-family:"Times New Roman",serif;
	letter-spacing:.2pt;}
p.MsoHeader, li.MsoHeader, div.MsoHeader
	{margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.MsoFooter, li.MsoFooter, div.MsoFooter
	{margin:0in;
	margin-bottom:.0001pt;
	font-size:9.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
a:link, span.MsoHyperlink
	{color:blue;
	text-decoration:underline;}
a:visited, span.MsoHyperlinkFollowed
	{color:purple;
	text-decoration:underline;}
p.MsoDocumentMap, li.MsoDocumentMap, div.MsoDocumentMap
	{margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	background:navy;
	font-size:12.0pt;
	font-family:"Tahoma",sans-serif;}
p.MsoCommentSubject, li.MsoCommentSubject, div.MsoCommentSubject
	{mso-style-link:"Comment Subject Char";
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	font-size:10.0pt;
	font-family:"Times New Roman",serif;
	letter-spacing:.2pt;
	font-weight:bold;}
p.MsoAcetate, li.MsoAcetate, div.MsoAcetate
	{mso-style-link:"Balloon Text Char";
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	font-size:9.0pt;
	font-family:"Segoe UI",sans-serif;
	letter-spacing:.2pt;}
span.11ptChar
	{mso-style-name:11ptChar;
	font-family:"Times New Roman",serif;}
span.BillHead
	{mso-style-name:BillHead;
	font-family:"Times New Roman",serif;
	font-variant:small-caps;
	font-weight:bold;}
span.BillHeading2
	{mso-style-name:BillHeading2;
	font-family:"Times New Roman",serif;
	font-variant:small-caps;
	font-weight:bold;}
span.BillHeadUnBold
	{mso-style-name:BillHeadUnBold;
	font-family:"Times New Roman",serif;
	font-variant:small-caps;}
span.BillLanguage
	{mso-style-name:BillLanguage;
	font-family:"Times New Roman",serif;
	font-style:italic;}
p.bpuBill, li.bpuBill, div.bpuBill
	{mso-style-name:bpuBill;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	line-height:120%;
	font-size:26.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
p.bpuHeadSpon, li.bpuHeadSpon, div.bpuHeadSpon
	{mso-style-name:bpuHeadSpon;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
span.bpuHeadSponChar
	{mso-style-name:bpuHeadSponChar;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
p.bpuIntro, li.bpuIntro, div.bpuIntro
	{mso-style-name:bpuIntro;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	line-height:120%;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.bpuLegislature, li.bpuLegislature, div.bpuLegislature
	{mso-style-name:bpuLegislature;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	line-height:120%;
	font-size:24.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
p.bpuNormText, li.bpuNormText, div.bpuNormText
	{mso-style-name:bpuNormText;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:120%;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.bpuReprint, li.bpuReprint, div.bpuReprint
	{mso-style-name:bpuReprint;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	line-height:120%;
	font-size:22.0pt;
	font-family:"Times New Roman",serif;
	letter-spacing:.2pt;}
p.bpuSponsor, li.bpuSponsor, div.bpuSponsor
	{mso-style-name:bpuSponsor;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:120%;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
p.bpuState, li.bpuState, div.bpuState
	{mso-style-name:bpuState;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	line-height:120%;
	font-size:32.0pt;
	font-family:"Arial",sans-serif;
	font-weight:bold;}
span.charMarlett
	{mso-style-name:charMarlett;
	font-family:Marlett;}
p.ElevenPt, li.ElevenPt, div.ElevenPt
	{mso-style-name:ElevenPt;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.FronterPage, li.FronterPage, div.FronterPage
	{mso-style-name:FronterPage;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	font-size:10.0pt;
	font-family:"Times New Roman",serif;}
p.FronterPage12pt, li.FronterPage12pt, div.FronterPage12pt
	{mso-style-name:FronterPage12pt;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.FronterPageBillHeading, li.FronterPageBillHeading, div.FronterPageBillHeading
	{mso-style-name:FronterPageBillHeading;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.2in;
	margin-bottom:.0001pt;
	text-align:justify;
	text-indent:-.2in;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	font-variant:small-caps;}
p.FronterPageTBox2, li.FronterPageTBox2, div.FronterPageTBox2
	{mso-style-name:FronterPageTBox2;
	margin:0in;
	margin-bottom:.0001pt;
	font-size:10.0pt;
	font-family:"Times New Roman",serif;}
p.FronterPageTextBox, li.FronterPageTextBox, div.FronterPageTextBox
	{mso-style-name:FronterPageTextBox;
	margin:0in;
	margin-bottom:.0001pt;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
p.FronterSameAs, li.FronterSameAs, div.FronterSameAs
	{mso-style-name:FronterSameAs;
	margin:0in;
	margin-bottom:.0001pt;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.HangingAnAct, li.HangingAnAct, div.HangingAnAct
	{mso-style-name:HangingAnAct;
	mso-style-link:"HangingAnAct Char";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.2in;
	margin-bottom:.0001pt;
	text-align:justify;
	text-indent:-.2in;
	line-height:120%;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	letter-spacing:.2pt;}
span.HangingAnActChar
	{mso-style-name:"HangingAnAct Char";
	mso-style-link:HangingAnAct;
	letter-spacing:.2pt;}
span.Para10pt
	{mso-style-name:Para10pt;
	font-family:"Times New Roman",serif;}
p.Pg2Footer, li.Pg2Footer, div.Pg2Footer
	{mso-style-name:Pg2Footer;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	font-size:8.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
p.StyleFronterPage11pt, li.StyleFronterPage11pt, div.StyleFronterPage11pt
	{mso-style-name:"Style FronterPage + 11 pt";
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.StyleFronterPageLoweredby3pt, li.StyleFronterPageLoweredby3pt, div.StyleFronterPageLoweredby3pt
	{mso-style-name:"Style FronterPage + Lowered by  3 pt";
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	font-size:10.0pt;
	font-family:"Times New Roman",serif;
	position:relative;
	top:3.0pt;}
p.StyleFronterSameAsPatternSolid100White, li.StyleFronterSameAsPatternSolid100White, div.StyleFronterSameAsPatternSolid100White
	{mso-style-name:"Style FronterSameAs + Pattern\: Solid \(100%\) \(White\)";
	margin:0in;
	margin-bottom:.0001pt;
	background:white;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.Style1, li.Style1, div.Style1
	{mso-style-name:Style1;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.5in;
	margin-bottom:.0001pt;
	text-align:justify;
	font-size:10.0pt;
	font-family:"Times New Roman",serif;}
span.Whereas
	{mso-style-name:Whereas;
	font-family:"Times New Roman",serif;
	font-variant:small-caps;
	font-weight:bold;}
span.Style10pt
	{mso-style-name:"Style 10 pt";
	font-family:"Times New Roman",serif;}
p.FronterPageNOCAPS, li.FronterPageNOCAPS, div.FronterPageNOCAPS
	{mso-style-name:FronterPageNOCAPS;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.2in;
	margin-bottom:.0001pt;
	text-align:justify;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.bpuWpGraphic, li.bpuWpGraphic, div.bpuWpGraphic
	{mso-style-name:bpuWpGraphic;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	line-height:120%;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	letter-spacing:.2pt;}
p.sponUdate, li.sponUdate, div.sponUdate
	{mso-style-name:sponUdate;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
span.fronterpagebillhead
	{mso-style-name:fronterpagebillhead;
	font-family:"Times New Roman",serif;
	font-variant:small-caps;}
p.FPHangingAnAct, li.FPHangingAnAct, div.FPHangingAnAct
	{mso-style-name:FPHangingAnAct;
	mso-style-link:"FPHangingAnAct Char";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.4in;
	margin-bottom:.0001pt;
	text-align:justify;
	text-indent:-.2in;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	letter-spacing:.2pt;}
span.FPHangingAnActChar
	{mso-style-name:"FPHangingAnAct Char";
	mso-style-link:FPHangingAnAct;
	letter-spacing:.2pt;}
span.LeftBrackt
	{mso-style-name:LeftBrackt;
	font-family:"Albertus Extra Bold",sans-serif;
	font-weight:bold;}
span.RightBrackt
	{mso-style-name:RightBrackt;
	font-family:"Albertus Extra Bold",sans-serif;
	font-weight:bold;}
span.BoldItal
	{mso-style-name:BoldItal;
	font-weight:bold;
	font-style:italic;}
p.HangingSup, li.HangingSup, div.HangingSup
	{mso-style-name:HangingSup;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.2in;
	margin-bottom:.0001pt;
	text-align:justify;
	text-indent:-.2in;
	line-height:120%;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	letter-spacing:.2pt;}
p.HangingTableBottom, li.HangingTableBottom, div.HangingTableBottom
	{mso-style-name:HangingTableBottom;
	margin-top:0in;
	margin-right:1.0in;
	margin-bottom:0in;
	margin-left:.8in;
	margin-bottom:.0001pt;
	text-indent:-.8in;
	line-height:120%;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	letter-spacing:.2pt;}
p.HangingTableTop, li.HangingTableTop, div.HangingTableTop
	{mso-style-name:HangingTableTop;
	margin-top:0in;
	margin-right:.5in;
	margin-bottom:0in;
	margin-left:.8in;
	margin-bottom:.0001pt;
	text-indent:-.8in;
	line-height:120%;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	letter-spacing:.2pt;}
span.BalloonTextChar
	{mso-style-name:"Balloon Text Char";
	mso-style-link:"Balloon Text";
	font-family:"Segoe UI",sans-serif;
	letter-spacing:.2pt;}
span.CommentTextChar
	{mso-style-name:"Comment Text Char";
	mso-style-link:"Comment Text";
	letter-spacing:.2pt;}
span.CommentSubjectChar
	{mso-style-name:"Comment Subject Char";
	mso-style-link:"Comment Subject";
	letter-spacing:.2pt;
	font-weight:bold;}
.MsoChpDefault
	{font-size:10.0pt;}
 /* Page Definitions */
 @page WordSection1
	{size:8.5in 14.0in;
	margin:1.5in 1.0in 1.0in 1.0in;}
div.WordSection1
	{page:WordSection1;}
@page WordSection2
	{size:8.5in 14.0in;
	margin:1.0in 113.75pt 1.0in 113.75pt;}
div.WordSection2
	{page:WordSection2;}
@page WordSection3
	{size:8.5in 14.0in;
	margin:1.0in 1.75in 1.3in 2.0in;}
div.WordSection3
	{page:WordSection3;}
-->
</style>

</head>

<body lang=EN-US link=blue vlink=purple>

<div class=WordSection1>

<p class=bpuBill><a name=bpuFrontPg></a>SENATE JOINT RESOLUTION </p>

<p class=bpuBill>No. 142 </p>

<p class=bpuWpGraphic><b><span style='font-size:32.0pt;line-height:120%;
font-family:"Arial",sans-serif;letter-spacing:0pt'>STATE OF NEW JERSEY</span></b></p>

<p class=bpuLegislature>221st LEGISLATURE</p>

<p class=bpuWpGraphic>  </p>

<p class=bpuIntro>INTRODUCED OCTOBER 24, 2024</p>

<p class=bpuIntro>&nbsp;</p>

</div>

<span style='font-size:11.0pt;line-height:120%;font-family:"Times New Roman",serif'><br
clear=all style='page-break-before:auto'>
</span>

<div class=WordSection2>

<p class=bpuIntro>&nbsp;</p>

<p class=bpuSponsor>Sponsored by:</p>

<p class=bpuSponsor>Senator  VIN GOPAL</p>

<p class=bpuSponsor>District 11 (Monmouth)</p>

<p class=bpuSponsor>Senator  ANGELA V. MCKNIGHT</p>

<p class=bpuSponsor>District 31 (Hudson)</p>

<p class=bpuSponsor>&nbsp;</p>

<p class=bpuSponsor>&nbsp;</p>

<p class=bpuSponsor>&nbsp;</p>

<p class=bpuSponsor>&nbsp;</p>

<p class=bpuSponsor>SYNOPSIS</p>

<p class=bpuNormText>     Designates last full week of September of each year
as Frontotemporal Degeneration Awareness Week in NJ.</p>

<p class=bpuNormText>&nbsp;</p>

<p class=bpuSponsor>CURRENT VERSION OF TEXT </p>

<p class=bpuNormText>     As introduced.</p>

<p class=bpuNormText>   </p>

</div>

<span style='font-size:12.0pt;line-height:120%;font-family:"Times New Roman",serif;
letter-spacing:.2pt'><br clear=all style='page-break-before:always'>
</span>

<div class=WordSection3>

<p class=HangingAnAct style='line-height:150%'><span class=BillHead>A Joint
Resolution</span><span class=HangingAnActChar> </span>designating Frontotemporal
Degeneration Awareness Week in New Jersey.</p>

<p class=MsoNormal style='line-height:150%'>&nbsp;</p>

<p class=MsoNormal style='margin-left:.2in;text-indent:-.2in;line-height:150%'><b><span
style='font-variant:small-caps'>Whereas,</span></b> Frontotemporal dementia
(FTD), or frontotemporal degeneration, refers to a group of disorders caused by
progressive nerve cell loss in the brains frontal lobes or temporal lobes; and
</p>

<p class=MsoNormal style='margin-left:.2in;text-indent:-.2in;line-height:150%'><b><span
style='font-variant:small-caps'>Whereas,</span></b> FTD is a terminal and
incurable neurodegenerative disease that causes impairments to speech, personality,
behavior, and motor skills; and </p>

<p class=MsoNormal style='margin-left:.2in;text-indent:-.2in;line-height:150%'><b><span
style='font-variant:small-caps'>Whereas,</span></b> FTD accounts for an
estimated five to 15 percent of all dementia cases; and</p>

<p class=MsoNormal style='margin-left:.2in;text-indent:-.2in;line-height:150%'><b><span
style='font-variant:small-caps'>Whereas,</span></b> FTD is the most common form
of dementia in individuals under 60; and </p>

<p class=MsoNormal style='margin-left:.2in;text-indent:-.2in;line-height:150%'><b><span
style='font-variant:small-caps'>Whereas,</span></b> On average, it takes about
3.6 years from the onset of FTD symptoms to receive an accurate diagnosis; and </p>

<p class=MsoNormal style='margin-left:.2in;text-indent:-.2in;line-height:150%'><b><span
style='font-variant:small-caps'>Whereas,</span></b> The average life expectancy
for someone with FTD is typically between seven and 13 years from the onset of
symptoms; and </p>

<p class=MsoNormal style='margin-left:.2in;text-indent:-.2in;line-height:150%'><b><span
style='font-variant:small-caps'>Whereas,</span></b> FTD can affect individuals
between the ages of 21 and 80, with the highest proportion of cases occurring
between 45 and 64. This often leaves people in the prime of life unable to work
or function normally; and</p>

<p class=MsoNormal style='margin-left:.2in;text-indent:-.2in;line-height:150%'><b><span
style='font-variant:small-caps'>Whereas, </span></b>FTD can be misdiagnosed as
Alzheimer's disease but unlike Alzheimers disease, FTD tends to occur at a
younger age; and </p>

<p class=MsoNormal style='margin-left:.2in;text-indent:-.2in;line-height:150%'><b><span
style='font-variant:small-caps'>Whereas,</span></b> The average annual cost of
care for a person living with FTD is roughly twice as high as the cost associated
with Alzheimers disease; and </p>

<p class=MsoNormal style='margin-left:.2in;text-indent:-.2in;line-height:150%'><b><span
style='font-variant:small-caps'>Whereas, </span></b>FTD is recognized as a
priority disease in The National Plan to Address Alzheimers Disease; and </p>

<p class=MsoNormal style='margin-left:.2in;text-indent:-.2in;line-height:150%'><b><span
style='font-variant:small-caps'>Whereas,</span></b> The National Plan to
Address Alzheimers Disease is a federal strategy that aims to reduce the
burden of Alzheimers disease and related dementias (AD/ADRD) by accelerating
research towards treatments, improving care and support for people facing these
conditions, and reducing the risk of AD/ADRD by promoting brain health; and </p>

<p class=MsoNormal style='margin-left:.2in;text-indent:-.2in;line-height:150%'><b><span
style='font-variant:small-caps'>Whereas,</span></b> Approximately 40 percent of
individuals living with FTD have a family history of the disease or a related
condition like <span style='color:#001D35;background:white'>amyotrophic lateral
sclerosis, also known as Lou Gehrig's disease</span>. Of those with a family
history, about half have an inherited form rare genetic mutations; and </p>

<p class=MsoNormal style='margin-left:.2in;text-indent:-.2in;line-height:150%'><b><span
style='font-variant:small-caps'>Whereas,</span></b> Due to its broad range of
cognitive and behavioral symptoms, FTD is often misdiagnosed as a psychiatric
condition or another neurodegenerative disease; and </p>

<p class=MsoNormal style='margin-left:.2in;text-indent:-.2in;line-height:150%'><b><span
style='font-variant:small-caps'>Whereas,</span></b> FTD frequently impairs a
persons ability to express emotions, demonstrate empathy, and show affection
toward loved ones; and </p>

<p class=MsoNormal style='margin-left:.2in;text-indent:-.2in;line-height:150%'><b><span
style='font-variant:small-caps'>Whereas,</span></b> An individual living with
FTD may lose their sense of social propriety and experience significant changes
in their personality. They might also struggle with understanding grammar, lose
the meaning of words, become hesitant in their speech, and may eventually
become mute; and</p>

<p class=MsoNormal style='margin-left:.2in;text-indent:-.2in;line-height:150%'><b><span
style='font-variant:small-caps'>Whereas,</span></b> A person living with FTD may
experience physical changes such as muscle weakness which can lead to loss of balance
and increased falls.  They may also experience difficulty speaking and
swallowing; and </p>

<p class=MsoNormal style='margin-left:.2in;text-indent:-.2in;line-height:150%'><b><span
style='font-variant:small-caps'>Whereas,</span></b> The Association for Frontotemporal
Degeneration is the leading national organization exclusively focused on the
spectrum of FTD disorders with a mission to improve the quality of life of people
affected by FTD and promote research in effort to find a cure; and</p>

<p class=MsoNormal style='margin-left:.2in;text-indent:-.2in;line-height:150%'><b><span
style='font-variant:small-caps'>Whereas,</span></b> Further research at both the
national and global level is needed to enhance our understanding of FTD; and </p>

<p class=MsoNormal style='margin-left:.2in;text-indent:-.2in;line-height:150%'><b><span
style='font-variant:small-caps'>Whereas,</span></b> In New Jersey there are an
estimated 185,000 people living with Alzheimers dementia.  It is unknown how
many New Jerseyans are living with FTD; and</p>

<p class=MsoNormal style='margin-left:.2in;text-indent:-.2in;line-height:150%'><b><span
style='font-variant:small-caps'>Whereas, </span></b>Increasing FTD awareness
through public events focused on the impact that FTD has on communities is key
to informing New Jerseyans of this often overlooked and incurable terminal
neurodegenerative medical condition; and </p>

<p class=MsoNormal style='margin-left:.2in;text-indent:-.2in;line-height:150%'><b><span
style='font-variant:small-caps'>Whereas, </span></b>Designating the last full
week of September as Frontotemporal Degeneration Awareness Week would provide
New Jerseyans with an annual reminder on the effects that FTD has on New
Jerseyans diagnosed with the medical condition; now, therefore,</p>

<p class=MsoNormal style='line-height:150%'>&nbsp;</p>

<p class=MsoNormal style='line-height:150%'>     <span class=BillHeading2>Be It
Resolved </span><span class=BillLanguage>by the Senate and General Assembly of
the State of New Jersey:</span></p>

<p class=MsoNormal style='line-height:150%'>&nbsp;</p>

<p class=MsoNormal style='line-height:150%'>     1.  The last full week of
September of each year shall be designated as Frontotemporal Degeneration Awareness
Week in New Jersey to bring awareness to frontotemporal degeneration and its
effect on New Jerseyans diagnosed with the medical condition.</p>

<p class=MsoNormal style='line-height:150%'>&nbsp;</p>

<p class=MsoNormal style='line-height:150%'>     2.  The Governor is
respectfully requested to annually issue a proclamation recognizing the last
full week of September as Frontotemporal Degeneration Awareness Week in New
Jersey, and calling upon public officials and the citizens of this State to
observe the month with appropriate activities and programs.</p>

<p class=MsoNormal style='line-height:150%'>&nbsp;</p>

<p class=MsoNormal style='line-height:150%'>     3.  This joint resolution
shall take effect immediately.<br clear=all style='page-break-before:always'>
</p>

<p class=MsoNormal align=center style='text-align:center;line-height:150%'>STATEMENT</p>

<p class=MsoNormal style='line-height:150%'>&nbsp;</p>

<p class=MsoNormal style='line-height:150%'>     This resolution designates the
last full week of September of each year as Frontotemporal Degeneration
Awareness Week in New Jersey. Frontotemporal dementia (FTD), or frontotemporal
degeneration, refers to a group of disorders caused by progressive nerve cell
loss in the brains frontal lobes or temporal lobes. FTD is a terminal and
incurable neurodegenerative disease that causes impairments to speech, personality,
behavior, and motor skills.  Approximately 40 percent of individuals living
with FTD have a family history of the disease or a related condition like <span
style='color:#001D35;background:white'>amyotrophic lateral sclerosis, also
known as Lou Gehrig's disease</span>.  Due to its broad range of cognitive and
behavioral symptoms, FTD is often misdiagnosed as a psychiatric condition or
another neurodegenerative disease.  An individual living with FTD may lose
their sense of social propriety and experience significant changes in their
personality. They might also struggle with understanding grammar, lose the
meaning of words, become hesitant in their speech, and may eventually become
mute.  A person living with FTD may also experience physical changes such as
muscle weakness which can lead to loss of balance and increased falls.</p>

<p class=MsoNormal style='line-height:150%'>     Research at both the national
and global level is needed to enhance our understanding of FTD and ultimately
discover a cure.  In New Jersey there are an estimated 185,000 people living
with Alzheimers dementia.  It is unknown how many New Jerseyans are living
with FTD.  Increasing FTD awareness through public events focused on the impact
that FTD has on communities is key to informing New Jerseyans of this often
overlooked and incurable terminal neurodegenerative medical condition.  Designating
the last full week of September as Frontotemporal Degeneration Awareness Week
would provide New Jerseyans with an annual reminder on the effects that FTD has
on New Jerseyans diagnosed with FTD.</p>

</div>

</body>

</html>
